GLMD
Galmed Pharmaceuticals Ltd
NASDAQ: GLMD · HEALTHCARE · BIOTECHNOLOGY
$0.56
-4.92% today
Updated 2026-04-29
Market cap
$4.12M
P/E ratio
—
P/S ratio
61.38x
EPS (TTM)
$-2.39
Dividend yield
—
52W range
$0 – $2
Volume
3.7M
Galmed Pharmaceuticals Ltd (GLMD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $467000.00 | $1.08M | $2.04M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | +132.3% | +87.8% | -100.0% | — | — | — | — | — | — |
| Cost of revenue | $5000.00 | $4000.00 | $9000.00 | $50000.00 | $17.18M | $13.21M | $0.00 | $35000.00 | $39000.00 | $42000.00 | $35000.00 | $31000.00 | $83000.00 | — |
| Gross profit | $-5000.00 | $-4000.00 | $-9000.00 | $-50000.00 | $467000.00 | $1.08M | $2.04M | $-35000.00 | $-39000.00 | $-42000.00 | $-35000.00 | $-31000.00 | $-83000.00 | — |
| Gross margin | — | — | — | — | 100.0% | 100.0% | 100.0% | — | — | — | — | — | — | — |
| R&D | $2.44M | $7.21M | $6.66M | $7.63M | $14.27M | $9.65M | $8.31M | $18.18M | $26.08M | $27.22M | $12.99M | $3.57M | $2.98M | $4.87M |
| SG&A | $694000.00 | $7.36M | $2.48M | $3.25M | $3.08M | $3.80M | $4.44M | $4.20M | $4.13M | $5.66M | $4.66M | $3.72M | $3.26M | $3.64M |
| Operating income | $-3.14M | $-14.56M | $-9.14M | $-10.88M | $-16.88M | $-12.36M | $-10.71M | $-22.38M | $-30.21M | $-32.88M | $-17.65M | $-7.49M | $-6.28M | $-8.51M |
| Operating margin | — | — | — | — | -3615.0% | -1139.5% | -525.8% | — | — | — | — | — | — | — |
| EBITDA | $-3.13M | $-14.56M | $-9.13M | $-10.82M | $-16.71M | $-12.13M | $-10.33M | $-22.34M | $-30.17M | $-32.84M | $-17.62M | $-7.46M | $-6.20M | $-8.51M |
| EBITDA margin | — | — | — | — | -3578.8% | -1117.5% | -506.8% | — | — | — | — | — | — | — |
| EBIT | $-3.14M | $-14.56M | $-9.14M | $-10.88M | $-16.88M | $-12.36M | $-10.71M | $-22.38M | $-30.21M | $-32.88M | $-17.65M | $-7.49M | $-6.28M | — |
| Interest expense | $0.00 | $34000.00 | $0.00 | $0.00 | $67000.00 | $49000.00 | $42000.00 | $33000.00 | $31000.00 | $43000.00 | $215000.00 | $11000.00 | $15000.00 | — |
| Income tax | $6000.00 | $1000.00 | $1000.00 | $21.24M | $106000.00 | $12.36M | $75000.00 | $-1.92M | $-1.16M | $-519000.00 | $705000.00 | $-14.98M | — | — |
| Effective tax rate | -0.2% | -0.0% | -0.0% | 200.0% | -0.6% | 19021.5% | -0.8% | 8.6% | 3.9% | 1.6% | -4.1% | 68.4% | 0.0% | 0.0% |
| Net income | $-3.15M | $-17.48M | $-9.10M | $-10.62M | $-16.95M | $-12.30M | $-9.86M | $-20.46M | $-28.77M | $-32.47M | $-17.87M | $-6.91M | $-7.52M | $-10.31M |
| Net income growth (YoY) | — | -455.3% | +47.9% | -16.7% | -59.6% | +27.5% | +19.9% | -107.6% | -40.6% | -12.8% | +45.0% | +61.3% | -8.8% | -37.1% |
| Profit margin | — | — | — | — | -3630.2% | -1133.5% | -483.6% | — | — | — | — | — | — | — |